Balyasny Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-8,251
| Closed | -$647K | – | 1458 |
|
|
2019
Q1 | $647K | Buy |
+8,251
| New | +$647K | ﹤0.01% | 1028 |
|
|
2018
Q4 | – | Sell |
-8,913
| Closed | -$1.53M | – | 1435 |
|
|
2018
Q3 | $1.53M | Buy |
8,913
+3,051
| +52% | +$522K | 0.01% | 866 |
|
|
2018
Q2 | $758K | Buy |
+5,862
| New | +$758K | ﹤0.01% | 1032 |
|
|
2017
Q4 | – | Sell |
-6,917
| Closed | -$587K | – | 1910 |
|
|
2017
Q3 | $587K | Buy |
+6,917
| New | +$587K | ﹤0.01% | 1105 |
|
|
2015
Q2 | – | Sell |
-77,863
| Closed | -$3.75M | – | 1005 |
|
|
2015
Q1 | $3.75M | Buy |
+77,863
| New | +$3.75M | 0.03% | 377 |
|